Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Breccia

Showing results (71-80 of 427) with videos related to

Pageof 43
Sort By:
Therapeutic Advances in Hematology|March 12, 2019
Insights into the optimal use of ponatinib in patients with chronic phase chronic myeloid leukaemiaMatteo Molica, Emilia Scalzulli, Gioia Colafigli, et al.
Bone Marrow Transplantation|September 20, 2019
The role of allogeneic stem-cell transplant in myelofibrosis in the era of JAK inhibitors: a case-based reviewMario Tiribelli, Francesca Palandri, Emanuela Sant'Antonio, et al.
Leukemia Research|July 22, 2016
Early molecular response in chronic myeloid leukemia and halving time: Latest evidencesMassimo Breccia, Matteo Molica, Gioia Colafigli, et al.
American Journal of Hematology|August 21, 2019
Maintenance therapy in AML: The past, the present and the futureMatteo Molica, Massimo Breccia, Roberto Foa, et al.
Current Opinion in Oncology|August 26, 2022
Novel therapeutic agents for myelofibrosis after failure or suboptimal response to JAK2 inhbitorsMassimo Breccia, Giovanni Manfredi Assanto, Alessandro Laganà, et al.
Cancers|June 26, 2026
Four Decades of Molecular Innovation in Chronic Myeloid Leukemia: From Antisense Targeting to Treatment-Free RemissionMaria Stefania De Propris, Alessandro Laganà, Massimo Breccia, et al.
Current Hematologic Malignancy Reports|October 20, 2022
CML Resistant to 2nd-Generation TKIs: Mechanisms, Next Steps, and New DirectionsEmilia Scalzulli, Ida Carmosino, Maria Laura Bisegna, et al.
Expert Review of Hematology|October 28, 2022
From bench to bedside: bridging the gaps in best practices for real-world chronic myeloid leukemia careGiovanni Manfredi Assanto, Emilia Scalzulli, Ida Carmosino, et al.
Journal of Hematology & Oncology|July 11, 2022
A clinician perspective on the treatment of chronic myeloid leukemia in the chronic phaseValentin García-Gutiérrez, Massimo Breccia, Elias Jabbour, et al.
Haematologica|July 20, 2004
Prognostic factors in myelodysplastic and myeloproliferative types of chronic myelomonocytic leukemia: a retrospective analysis of 83 patients from a single institutionMassimo Breccia, Roberto Latagliata, Andrea Mengarelli, et al.
Pageof 43

Showing results (71-80 of 427) with videos related to

Sort By:
Pageof 43
Therapeutic Advances in Hematology|March 12, 2019
Insights into the optimal use of ponatinib in patients with chronic phase chronic myeloid leukaemiaMatteo Molica, Emilia Scalzulli, Gioia Colafigli, et al.
Bone Marrow Transplantation|September 20, 2019
The role of allogeneic stem-cell transplant in myelofibrosis in the era of JAK inhibitors: a case-based reviewMario Tiribelli, Francesca Palandri, Emanuela Sant'Antonio, et al.
Leukemia Research|July 22, 2016
Early molecular response in chronic myeloid leukemia and halving time: Latest evidencesMassimo Breccia, Matteo Molica, Gioia Colafigli, et al.
American Journal of Hematology|August 21, 2019
Maintenance therapy in AML: The past, the present and the futureMatteo Molica, Massimo Breccia, Roberto Foa, et al.
Current Opinion in Oncology|August 26, 2022
Novel therapeutic agents for myelofibrosis after failure or suboptimal response to JAK2 inhbitorsMassimo Breccia, Giovanni Manfredi Assanto, Alessandro Laganà, et al.
Cancers|June 26, 2026
Four Decades of Molecular Innovation in Chronic Myeloid Leukemia: From Antisense Targeting to Treatment-Free RemissionMaria Stefania De Propris, Alessandro Laganà, Massimo Breccia, et al.
Current Hematologic Malignancy Reports|October 20, 2022
CML Resistant to 2nd-Generation TKIs: Mechanisms, Next Steps, and New DirectionsEmilia Scalzulli, Ida Carmosino, Maria Laura Bisegna, et al.
Expert Review of Hematology|October 28, 2022
From bench to bedside: bridging the gaps in best practices for real-world chronic myeloid leukemia careGiovanni Manfredi Assanto, Emilia Scalzulli, Ida Carmosino, et al.
Journal of Hematology & Oncology|July 11, 2022
A clinician perspective on the treatment of chronic myeloid leukemia in the chronic phaseValentin García-Gutiérrez, Massimo Breccia, Elias Jabbour, et al.
Haematologica|July 20, 2004
Prognostic factors in myelodysplastic and myeloproliferative types of chronic myelomonocytic leukemia: a retrospective analysis of 83 patients from a single institutionMassimo Breccia, Roberto Latagliata, Andrea Mengarelli, et al.
Pageof 43